
    
      1. Detect the prevalence of parasite/s associated with Inflammatory bowel diseases (IBD)
           and Irritable bowel syndrome (IBS) in comparison with control subjects.

        2. Evaluating the effect of the parasite on the course and prognosis of the diseases.

        3. Evaluating the effect of the antiparasitic drugs on the course and prognosis of the
           diseases.
    
  